Rubius Therapeutics Inc. (RUBY) Declined -5.9% or -1.46 To Price $23.2 On Wednesday


Rubius Therapeutics Inc. (RUBY) declined -5.9% or -1.46 to $23.2. It is near to 122389 shares traded, which is 60.46% compare to the average total volume 202441. The market cap of RUBY is $1.79 billion. The year to date change is -4.25%. The 52 week price range is from $19.78 to $33.01. Price of RUBY have changed 0.61% during last week. It have changed 16.77% over last month, 1.65% over last 3 months, 1.65% over last 6 months and 1.65% over one year.

The 52-week High is 33.01. It is 42.28% from the current price. The 52-week Low is 19.78. It is -14.74% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of RUBY is 2.12 on 2018-08-15. Short % to float is 1.55%. There are some statistics of RUBY. It is has market cap $1.79 billion. The share outstanding is 77.33 million. The average volume is 202441. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RUBY is -29.14%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RUBY is -25.86%.


Tags:

Share this post